A 62-year-old man is evaluated during a follow-up visit for difficult-to-control hypertension. He also has chronic kidney disease and hyperlipidemia. Following a physical exam and lab studies, what is the most appropriate additional treatment?
24 Aug 2021
Courses of oral corticosteroids for 14 or fewer days are associated with GI bleeding, sepsis, and heart failure, with the highest risks occurring within the first month of initiation, according to a Taiwanese study.
7 Jul 2020
Although use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors rose overall between 2015 and 2019, patients who were Black, Asian, female, or with lower household income had lower rates of prescriptions for the drug class than others with type 2 diabetes.
20 Apr 2021
Over a third of patients with chronic kidney disease (CKD) enrolled in a Medicare plan's Medication Therapy Management program in 2018 received a prescription for at least one potentially inappropriate medication.
2 Feb 2021
Women were significantly less likely than men to underestimate their bleeding risk, and a history of bleeding was associated with a threefold increased likelihood of inaccurate perception of bleeding risk, according to a study of atrial fibrillation patients.
24 Aug 2021
Data from the Childhood Cancer Survivor Study were used to examine the cumulative incidence of reported heart failure, coronary artery disease (CAD), valvular heart disease, pericardial disease, and arrhythmias according to decade of treatment (1970s, 1980s, or 1990s).
28 Jan 2020
The Infectious Diseases Society of America and Society for Healthcare Epidemiology of America made three new recommendations in a focused update of their guidelines on Clostridioides difficile infection.
29 Jun 2021
High-dose flu vaccine may not be more effective than standard dose in patients with high-risk cardiovascular disease
An industry-funded randomized trial in the U.S. and Canada found no significant difference between a high-dose group versus a standard-dose group in the time to first occurrence of all-cause death or cardiopulmonary hospitalization during three flu seasons.
15 Dec 2020
HRT for 10 years appears to cut risk of heart failure and heart attack without increasing cancer, deep venous thrombosis or stroke
Women who take hormone replacement therapy (HRT) for 10 years after menopause may have a significantly reduced risk of mortality, heart failure and heart attack without any increased risk of cancer, deep venous thrombosis or stroke, a study found.
16 Oct 2012
A cross-sectional survey at two U.S. academic medical centers asked older outpatients with mild cognitive impairment and normal cognition as well as patient-designated surrogates about treatment preferences in six health scenarios.
18 May 2021